Funding and Investment
The pre-seed round: $50,000 to $100,000
MedClinicX is seeking pre-seed funding to finish its initial product, validate it with US practices and start commercial sales. The company is pre-revenue, and this page is an invitation to talk, not an offer of securities.
Company stage
Early-stage, pre-seed
Current revenue
Pre-revenue
Funding sought
$50,000 to $100,000
Primary market
United States
Investment preferences
- Equity investment
- Strategic investment
- Commercial partnerships
- Accelerator and startup investment opportunities
Why we are raising
The products are designed and demonstrated, and the architecture is in place. What the company cannot do on its own at this stage is finish the initial product properly, run structured pilots in the US, and fund the security and compliance work that healthcare software requires. This round pays for that work, at a scale matched to the stage: enough to reach first recurring revenue and real evidence, not more.
Use of funds
What the funding would support
Product development
Finish the MVP of the initial product, then usability work driven by pilot feedback.
US market validation
Demonstrations, pilot recruitment and pricing tests with independent US practices.
Sales and marketing
Direct outreach, content and search work, and partnership development.
Team expansion
Contractors first, then hires, across engineering and customer support as pilots demand.
Security and compliance
Independent review of data handling, access controls and the requirements that apply before products process real patient data at scale.
Proposed milestones
- MVP of the initial product completed and demonstrated.
- First pilot practices live and giving structured feedback.
- Pricing validated with paying pilot customers.
- Initial product launched commercially with subscription plans.
- First recurring revenue established.
Illustrative allocation
How a $75,000 raise could be allocated
The table shows the proposed allocation for a $75,000 fundraising scenario, the middle of the range we are seeking. It is a plan, and it is subject to change as the work reveals what matters most.
| Area | Proposed amount | Share |
|---|---|---|
| Product Development | $25,000 | 33% |
| Sales and Marketing | $18,000 | 24% |
| Team and Contractors | $14,000 | 19% |
| Security and Compliance | $8,000 | 11% |
| Operations and Legal | $5,000 | 7% |
| Reserve | $5,000 | 7% |
| Total | $75,000 | 100% |
What this page does not do
This page does not promise a particular equity percentage, a company valuation, an investment return or a guaranteed exit, and it is not a public securities offering or a subscription mechanism. Investment terms are discussed privately with qualified investors, with legal review on both sides. Anyone considering an investment in an early-stage company should understand that the capital is at risk, including the risk of losing it in full.
Discuss an Investment Opportunity
Tell us who you are and what interests you. We will reply personally, and we are glad to share the investor presentation with qualified investors on request.
Investor information disclaimer. MedClinicX is an early-stage, pre-seed company and is not currently generating revenue. The information on these pages is provided for general information and relationship building. It is not a public offering of securities, and it is not investment advice. No valuation, equity percentage, investment return or exit is promised or implied. Figures labelled as projections, assumptions, illustrations or targets are forward looking statements about what the company intends to pursue, not results that have been achieved. Anyone considering an investment should carry out their own review and take independent professional advice. Please also read our Privacy Policy and Terms of Service.